Overview

A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Status:
Not yet recruiting
Trial end date:
2030-06-01
Target enrollment:
Participant gender:
Summary
Because of their prolonged survival, patients with 1p/19q-codeleted low-grade oligodendrogliomas treated with RT + PCV are at risk of neurocognitive deterioration. We make the hypothesis that withholding radiotherapy until tumor progression could reduce the risk of neurocognitive deterioration without impairing overall survival.
Phase:
Phase 3
Details
Lead Sponsor:
Hospices Civils de Lyon